Antipsychotics, particularly the first generation antipsychotics, are a leading cause. Mood stabilizers and atypical antipsychotics are commonly prescribed. Placental exposure is least for quetiapine compared to other atypical antipsychotics. These drugs include other opioids, antihistamines, antipsychotics, and anticholinergics. The most common typical antipsychotics associated with EPS are haloperidol and fluphenazine. In a 2013 comparison of 15 antipsychotics in schizophrenia, haloperidol demonstrated standard effectiveness. Some of the medications include&colon; glucocorticoids, thiazides, beta blockers, atypical antipsychotics, and statins. Data on treatment efficacies are strongest for atypical antipsychotics. Haloperidol is relatively inexpensive, being up to 100 fold less expensive than newer antipsychotics. From chlorpromazine a number of other similar antipsychotics were developed. Interactions can occur from typical antipsychotics or atypical antipsyhcotics. Weight gain is also less of a concern with ziprasidone compared to other atypical antipsychotics. The stopping of antipsychotics in schizophrenia and psychoses needs monitoring. The side effects reportedly associated with the various atypical antipsychotics vary and are medication-specific. It is usually classed with the atypical antipsychotics.